ArticlePharmaceuticals (Basel, Switzerland)2023

Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential.

Muhammad Mujammami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.